MH

Michelle L. Hastings

IP Ionis Pharmaceuticals: 3 patents #47 of 173Top 30%
TH The Mclean Hospital: 3 patents #21 of 118Top 20%
📍 North Chicago, IL: #13 of 78 inventorsTop 20%
🗺 Illinois: #6,670 of 84,256 inventorsTop 8%
Overall (All Time): #369,615 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12042508 Antisense compounds targeting genes associated with cystic fibrosis 2024-07-23
11732260 Compounds and methods for the modulation of amyloid-β precursor protein Frank Rigo 2023-08-22
11116785 Antisense compounds targeting genes associated with cystic fibrosis 2021-09-14
10787669 Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease Ole Isacson, Joanna A. Korecka-Roet 2020-09-29
10544417 Antisense compounds targeting genes associated with cystic fibrosis 2020-01-28
10525076 Antisense compounds targeting genes associated with cystic fibrosis 2020-01-07
10472634 Antisense compounds targeting apolipoprotein E receptor 2 Frank Rigo 2019-11-12
10370667 Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease Ole Isacson, Joanna A. Korecka-Roet 2019-08-06
9840709 Antisense compounds targeting genes associated with cystic fibrosis 2017-12-12
9840710 Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease Ole Isacson, Joanna A. Korecka-Roet 2017-12-12
9556434 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome 2017-01-31
9353371 Antisense compounds targeting genes associated with usher syndrome Frank Rigo, C. Frank Bennett 2016-05-31
8648053 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome 2014-02-11